StockData
Tronox Holdings plc logo

Tronox Holdings plc (TROX) stock analysis

TROXNYSEIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3078% below fair value
$2.82−0.03 (-1.05%)

Close on Nov 11, 2026Market cap $450.35MP/E –Yield 12.41%

StockData Score

Prices as of Nov 11, 2026How the score works

Value3Growth1Performance0Health1Dividend3

Weak8 of 30 checks passed

Tronox passes 8 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
1/6
Past performance
0/6
Financial health
1/6
Dividend
3/6

What stands out

  • Margin of safety over 20%

    The price is 78.2% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $2.82 is below our fair value estimate of $12.93.

  • P/B below the industry

    Tronox's price-to-book of 0.40 is below the Chemicals and Allied Products median of 1.25.

  • Growing faster than the industry

    Revenue grew 12.0% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

What to watch

  • Return on equity under 15%

    Return on equity was -37.6% over the last twelve months and averaged -1.7% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -2.9%, below the 10% that usually covers the cost of capital.

  • High debt

    Debt is 285% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew -5.7% a year over the last three fiscal years, short of the 10% we look for.

Valuation3/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA above its 5-year median

    Tronox's EV/EBITDA of 24.5 is above its 5-year median of 9.3.

  • P/B below the industry

    Tronox's price-to-book of 0.40 is below the Chemicals and Allied Products median of 1.25.

  • Trading below fair value

    The share price of $2.82 is below our fair value estimate of $12.93.

  • Margin of safety over 20%

    The price is 78.2% below fair value, more than the 20% cushion we look for.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew -5.7% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 12.0% over the last twelve months; the Chemicals and Allied Products median is 8.2%.

  • Guidance issued

    The latest outlook (Q3 2026 Adjusted EBITDA, Aug 6, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin slipping

    Gross margin was 6.8% over the last twelve months, against 12.2% a year earlier.

Past performance0/6
  • Return on equity under 15%

    Return on equity was -37.6% over the last twelve months and averaged -1.7% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -2.9%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    Tronox's return on equity of -37.6% is below the Chemicals and Allied Products median of -0.8%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was -15.9% over the last twelve months, against a 5-year average of -1.3%.

  • Net margin below the industry

    Tronox's net margin of -15.9% is below the Chemicals and Allied Products median of -0.4%.

Financial health1/6
  • High debt

    Debt is 285% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 196% five years ago to 285%.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 6.9% of total debt; we look for at least 20%.

  • Interest not well covered

    Operating income covers interest expense -0.7 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 2.52 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 0.69; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Tronox paid dividends worth 5.3% of the share price over the last twelve months.

  • Yield above Treasuries

    The 5.3% yield is above the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Tronox yields 5.3%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 8 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$12.93

The share price is 78% below this estimate.

20%+ below
Near fair value
20%+ above
$2.82Price$12.93Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/B1.1×1.0×1.2×$7.7450%
P/S0.9×0.6×1.2×$18.1350%
Fair value$12.93100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$9.23M
Value traded per 1% price move
$3.49M

Downside

High risk

Typical loss in a bad month
27.6%
Volatility (annualized)
80%
Sharpe ratio, 1 year
-0.33
Beta to the S&P 500 (5Y)
1.68

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

9.3%−13.2 pts over 5 years

Operating margin

-8.7%−18.6 pts over 5 years

Net margin

-16.2%−51.4 pts over 5 years

See a number that looks wrong?